Gilead Sciences Inc. et al. v. Canada (Minister of Health) et al., 2016 FC 857

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 430 N.R. 326 (FCA)
• Allergan Inc. v. Apotex Inc., 2016 FC 344



See all quotations

• Shire Canada Inc. v. Apotex Inc. et al., 2016 FC 382
• Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2016 FC 231
• Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2016 FCA 140
• Takeda Canada Inc. et al. v. Canada (Minister of Health) et al., (2015) 480 F.T.R. 82 (FC)
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2015) 474 N.R. 296 (FCA)
• Teva Canada Innovation et al. v. Apotex Inc. et al., 2014 FC 1070
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2014) 457 F.T.R. 227 (FC)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Weatherford Canada Ltd. et al. v. Corlac Inc. et al., (2011) 422 N.R. 49 (FCA)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Gilead Sciences Inc. et al. v. Canada (Minister of Health) et al., (2013) 445 F.T.R. 1 (FC)
• 671905 Alberta Inc. et al. v. Q'Max Solutions Inc., (2003) 305 N.R. 137 (FCA)
• Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2015 FC 610
• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2015 FC 875
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2014) 465 N.R. 306 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2009) 392 N.R. 96 (FCA)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., 2008 FCA 108
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)
• Eli Lilly Canada Inc. et al. v. Novopharm Ltd., (2010) 405 N.R. 1 (FCA)
• Merck & Co. et al. v. Pharmascience Inc. et al., (2010) 368 F.T.R. 1 (FC)
• Apotex Inc. v. Wellcome Foundation Ltd., [2002] 4 SCR 153
• Free World Trust v. Électro Santé Inc., [2000] 2 SCR 1024
• Windsurfing International Inc. v Tabur Marine (Great Britain) Ltd
• Pozzoli v BDMO
• Saint-Gobain PAM SA v Fusion Provida Ltd
• The General Tire & Rubber Company v The Firestone Tyre and Rubber Company Ltd and Others
• Orica Ltd v Commissioner of Taxation
• Du Pont de Nemours (E.I) & Company (Witsiepe's) Application